The Roger Williams Institute of Liver Studies

The Roger Williams Institute of Liver Studies (RW-ILS) is at the forefront of delivering world-leading discovery science and translating it into impactful solutions for patients with liver disease. By working closely with local public and patient groups throughout the research journey, we ensure our innovations are relevant, transformative, and centred around patient needs. As a pioneering collaboration between the Foundation for Liver Research, King’s College London, and King’s College Hospital NHS Foundation Trust, we bridge the gap between cutting-edge science and real-world patient outcomes. Our approach integrates clinical expertise with advanced research to tackle liver disease from every angle. Driving Excellence Across Five Research Themes: - Transplantation, Advanced Therapies & Regenerative Medicine - Steatotic Liver Diseases - Cirrhosis & the Gut-Liver Axis - Hepatobiliary Cancer - Paediatric Hepatology & Rare Diseases Our mission extends beyond research. We actively engage in policy development to shape healthcare practices and improve patient access to innovative treatments. We are outward-looking, fostering dynamic collaborations with leading researchers, industry partners, and policymakers across the UK and internationally. We are committed to training the next generation of scientists and healthcare professionals to work seamlessly together, tackling complex liver problems with interdisciplinary expertise. Our educational initiatives ensure that future leaders are equipped to address the evolving challenges of liver disease. Under the scientific leadership of Director Professor Philip Newsome and Deputy Director Professor Alberto Sanchez-Fueyo, the RW-ILS encompasses over 15 scientific groups with more than 100 staff and students. Our state-of-the-art facilities are located on the Denmark Hill campus of King’s College London.